arrow
A

Alessandra Bisagni

azienda usl—irccs di reggio emilia
H指数:22
被引数:1,402

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review

会阴切开部位转移性癌:一项系统文献综述

Cancers
IF4.4
2026-03-030
OAAI
Deciphering the immune molecular signature associated with pembrolizumab efficacy in the neoadjuvant setting of Triple-Negative Breast Cancer patients: a single-centre experience

解读与pembrolizumab在三阴性乳腺癌患者新辅助治疗中的疗效相关的免疫分子特征: 单中心经验

2024-05-020
PRE
Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination
2024-01-123
OAAI
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+Breast Cancer

基于残余癌负荷和肿瘤浸润淋巴细胞对HER2乳腺癌新辅助治疗后残余病变的预后模型

2023-07-074
OAAI
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes

关于PD-L1在前列腺癌中的表达,我们必须了解什么?系统文献综述 (第6部分): PD-L1表达与错配修复系统,BRCA,PTEN和其他基因状态的相关性

2022-01-2217
OAAI
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy
2021-12-066
OA
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic Correlations

关于PD-L1在前列腺癌中的表达,我们必须了解什么?系统性文献综述。第二部分:临床与病理相关性

CELLS
IF5.2
2021-11-1412
OAAI
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables

关于PD-L1在前列腺癌中的表达,我们必须了解什么?系统性文献综述。第1部分:聚焦免疫组织化学结果,并探讨分析前及结果解读中的影响因素

CELLS
IF5.2
2021-11-1422
OAAI
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH
2021-09-018
OAAI
Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed

对比增强乳腺x线摄影在评估肿瘤床钙化的乳腺癌患者对新辅助化疗的反应中的准确性和可重复性

2021-03-0410
OAAI
Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature

在同一原发切除标本中并存的高分化和未分化甲状腺癌: 连续13例病例中两种成分的免疫表型和遗传比较及文献复习

2020-07-1827
PREAI
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer

高水平的Notch胞内裂解结构域与晚期结肠癌患者的stemness和降低贝伐单抗疗效相关

2019-10-0114
OAAI
Angiosarcoma and anaplastic carcinoma of the thyroid are two distinct entities: a morphologic, immunohistochemical, and genetic study

甲状腺血管肉瘤和间变性癌是两个不同的实体: 形态学,免疫组织化学和遗传学研究

2019-06-0123
OAAI